Genfit 주식 가격. GNFT - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

3.48

매수가

3.48

매도가

3.49

거래량

264,831

3.32 일간 변동폭 3.55

3.025 52주 범위 5.86

market_cap

173.426M

전일 종가

3.36

개장가

3.40

최근 거래 시간

3.48

마지막 거래 시간

21:38:13

재정 규모

VWAP

평균 볼륨(3m)

203,324

발행 주식

49,834,983

배당수익률

주가수익률

-6.00

주당순이익(EPS)

-0.58

매출

38.68M

순이익

-28.89M

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.genfit.com

본부

Loos, Nord, Fra

설립됨

Genfit is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker GNFT. The last closing price for Genfit was 3.36 €. Over the last year, Genfit shares have traded in a share price range of 3.025 € to 5.86 €.

Genfit currently has 49,834,983 shares in issue. The market capitalisation of Genfit is 167.45 € million. Genfit has a price to earnings ratio (PE ratio) of -6.00.

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial

GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 13 janvier 2025 –...

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland) January 13, 2025 – GENFIT (Nasdaq...

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from...

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

GENFIT Reports Third Quarter 2024 Financial Information

GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

GENFIT : Information financière du troisième trimestre 2024

GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

GENFIT Reports Third Quarter 2024 Financial Information

Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30, 2024, including the €48.7 million milestone invoiced in...

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 23, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.06	1.75438596491	3.42	3.55	3.265	118417	3.33080906	DE
4	0.02	0.578034682081	3.46	3.69	3.265	115502	3.46963921	DE
12	-1.64	-32.03125	5.12	5.63	3.265	203324	4.21870501	DE
26	-0.53	-13.216957606	4.01	5.86	3.265	231985	4.51475714	DE
52	0.29	9.09090909091	3.19	5.86	3.025	244967	4.29327026	DE
156	-0.508	-12.7382146439	3.988	5.86	2.804	192538	3.88686354	DE
260	-14.93	-81.0972297664	18.41	20.96	2.746	302044	5.16788181	DE

GNFT - Frequently Asked Questions (FAQ)

What is the current Genfit share price?

The current share price of Genfit is 3.48 €

How many Genfit shares are in issue?

Genfit has 49,834,983 shares in issue

What is the market cap of Genfit?

The market capitalisation of Genfit is EUR 167.45M

What is the 1 year trading range for Genfit share price?

Genfit has traded in the range of 3.025 € to 5.86 € during the past year

What is the PE ratio of Genfit?

The price to earnings ratio of Genfit is -6

What is the cash to sales ratio of Genfit?

The cash to sales ratio of Genfit is 4.48

What is the reporting currency for Genfit?

Genfit reports financial results in EUR

What is the latest annual turnover for Genfit?

The latest annual turnover of Genfit is EUR 38.68M

What is the latest annual profit for Genfit?

The latest annual profit of Genfit is EUR -28.89M

What is the registered address of Genfit?

The registered address for Genfit is PARC EURASANTE, 885 AVENUE EUGENE AVINEE, LOOS, NORD, 59120

What is the Genfit website address?

The website address for Genfit is www.genfit.com

Which industry sector does Genfit operate in?

Genfit operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ALMASMastrad	0.0124 € (55.00%)	8.06M
MLSMLSmalto	0.021 € (50.00%)	5k
GTRDSGroupe Tera DS	0.075 € (28.21%)	22.66k
ALTBGBlockchain GP	0.384 € (25.90%)	4.63M
HYPDSHipay Group DS	0.02 € (21.95%)	70.64k
DRVDSDrone Volt DS	0.0012 € (-69.23%)	535.69k
ALCYBCybergun	0.0001 € (-50.00%)	5.84M
ALSAFSAFE	0.025 € (-16.39%)	246.73k
MLMADMade	10.20 € (-15.00%)	48
ALALOAcheterLouerFR	0.0724 € (-14.72%)	65.26k
ATOAtos SE	0.002 € (0.00%)	399.1M
BCPBanco Comercial Portugues SA	0.5044 € (1.12%)	30.06M
ALMASMastrad	0.0124 € (55.00%)	8.06M
ALVERVergnet	0.0016 € (6.67%)	7.3M
ALHPIHopium SA	0.0038 € (-2.56%)	7.14M